title: Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism.
abstract: In mammals, the catabolic pathway of phenylalanine and tyrosine is found in liver (hepatocytes) and kidney (proximal tubular cells). There are well-described human diseases associated with deficiencies of all enzymes in this pathway except for maleylacetoacetate isomerase (MAAI), which converts maleylacetoacetate (MAA) to fumarylacetoacetate (FAA). MAAI is also known as glutathione transferase zeta (GSTZ1). Here, we describe the phenotype of mice with a targeted deletion of the MAAI (GSTZ1) gene. MAAI-deficient mice accumulated FAA and succinylacetone in urine but appeared otherwise healthy. This observation suggested that either accumulating MAA is not toxic or an alternate pathway for MAA metabolism exists. A complete redundancy of MAAI could be ruled out because substrate overload of the tyrosine catabolic pathway (administration of homogentisic acid, phenylalanine, or tyrosine) resulted in renal and hepatic damage. However, evidence for a partial bypass of MAAI activity was also found. Mice doubly mutant for MAAI and fumarylacetoacetate hydrolase (FAH) died rapidly on a normal diet, indicating that MAA could be isomerized to FAA in the absence of MAAI. Double mutants showed predominant renal injury, indicating that this organ is the primary target for the accumulated compound(s) resulting from MAAI deficiency. A glutathione-mediated isomerization of MAA to FAA independent of MAAI enzyme was demonstrated in vitro. This nonenzymatic bypass is likely responsible for the lack of a phenotype in nonstressed MAAI mutant mice.
authors.affiliation: Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon, USA. dbbfjc@unileon.es
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Fernández-Cañón
authors.forename: Manfred W
authors.initials: MW
authors.lastname: Baetscher
authors.forename: Milton
authors.initials: M
authors.lastname: Finegold
authors.forename: Terry
authors.initials: T
authors.lastname: Burlingame
authors.forename: K Michael
authors.initials: KM
authors.lastname: Gibson
authors.forename: Markus
authors.initials: M
authors.lastname: Grompe
mesh_terms: D000090:Acetoacetates / Q000652:urine; D000818:Animals; D004032:Diet; D005260:Female; D005978:Glutathione / Q000378:metabolism*; D006713:Homogentisic Acid / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D014443:Tyrosine / Q000378:metabolism*; D019745:cis-trans-Isomerases / Q000172:deficiency / Q000235:genetics*
chemical_list: D000090:Acetoacetates; C105171:fumarylacetoacetate; D014443:Tyrosine; D019745:cis-trans-Isomerases; C021531:maleylacetoacetate isomerase; D005978:Glutathione; D006713:Homogentisic Acid